CEFOTAXIME SODIUM | A062659 | SANOFI AVENTIS US LLC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Hospira, Inc. - Citizen Petition FDA-2011-P-0173 · 4 docket documents Hospira, Inc. filed this citizen petition on March 17, 2011, requesting that the FDA designate Sanofi-Aventis's CLAFORAN (Cefotaxime for Injection) 1g and 2g in ADD-Vantage Vial, ANDA 062659, as an additional Reference Listed Drug under Section 505(j) of the Federal Food, Drug and Cosmetic Act to en | 505(q) | 2011-03-25 | Granted | — |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.